Daphne Lainson

Daphne Lainson is a principal in Smart & Biggar's Ottawa office and leader of the firm's life science practice. With close to 25 years of experience in law and patent agency and an advanced degree in chemistry, she has been entrusted with protecting inventions across the spectrum of chemical innovation. Daphne enthusiastically champions and effectively safeguards her clients’ intellectual property rights relating to new drugs, biologics, medical devices, consumer products, agrochemicals, specialty chemicals, industrial chemical processes, oil, gas, and petrochemicals. Daphne provides strategic advice and counselling to clients across the life cycle of a drug, including during pre-clinical and clinical development through to marketing and loss of exclusivity. She also offers strategic advice regarding patents and data protection, including patent listing under the Patented Medicines (Notice of Compliance) Regulations, certificates of supplementary protection, pricing, and reimbursement including Patented Medicine Prices Review Board matters (PMPRB).